Intervention Review

You have free access to this content

Oral zinc for treating diarrhoea in children

  1. Marzia Lazzerini1,*,
  2. Luca Ronfani2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 30 NOV 2010

DOI: 10.1002/14651858.CD005436.pub2

Database Title

Additional Information

How to Cite

Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD005436. DOI: 10.1002/14651858.CD005436.pub2.

Author Information

  1. 1

    WHO Collaborating Centre for Maternal and Child Health, Unit of Research on Health Services and International Health, Trieste, Italy

  2. 2

    IRCCS Burlo Garofolo, Unit of Clinical Epidemiology and Biostastics, Trieste, Italy

*Marzia Lazzerini, Unit of Research on Health Services and International Health, WHO Collaborating Centre for Maternal and Child Health, Via dei Burlo 1,34123, Trieste, Italy. lazzerini@burlo.trieste.it.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (1367K)Full (1568K)
[Figure 1]
Figure 1. Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
[Figure 2]
Figure 2. Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
[Figure 3]
Figure 3. Zinc vs placebo for acute diarrhoea: diarrhoea duration (h)
[Figure 4]
Figure 4. Zinc vs placebo for acute diarrhoea: diarrhoea on day 3
[Figure 5]
Figure 5. Zinc vs placebo for acute diarrhoea: diarrhoea on day 5
[Figure 6]
Figure 6. Zinc vs placebo for acute diarrhoea: diarrhoea on day 7
[Figure 7]
Figure 7. Zinc vs placebo for acute diarrhoea: Adverse events (vomiting)
[Figure 8]
Figure 8. Forest plot of comparison: 2 Zinc vs placebo for mean acute diarrhoea duration: subgroup analysis excluding children < 6 months, outcome: 2.1 Diarrhoea duration (h).
[Figure 9]
Figure 9. Forest plot of comparison: 3 Zinc vs placebo for acute diarrhoea on day 7: subgroup analysis excluding children < 6 months, outcome: 3.1 Diarrhoea on day 7.
[Figure 10]
Figure 10. Zinc vs placebo for persistent diarrhoea: diarrhoea duration (h)
[Analysis 1.1]
Analysis 1.1. Comparison 1 Zinc vs placebo for acute diarrhoea, Outcome 1 Diarrhoea duration (h).
[Analysis 1.2]
Analysis 1.2. Comparison 1 Zinc vs placebo for acute diarrhoea, Outcome 2 Diarrhoea on day 3.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Zinc vs placebo for acute diarrhoea, Outcome 3 Diarrhoea on day 5.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Zinc vs placebo for acute diarrhoea, Outcome 4 Diarrhoea on day 7.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Zinc vs placebo for acute diarrhoea, Outcome 5 Stool frequency (stools /day).
[Analysis 1.6]
Analysis 1.6. Comparison 1 Zinc vs placebo for acute diarrhoea, Outcome 6 Adverse events (vomiting).
[Analysis 2.1]
Analysis 2.1. Comparison 2 Zinc vs placebo for mean acute diarrhoea duration: subgroup analysis excluding children < 6 months, Outcome 1 Diarrhoea duration (h).
[Analysis 3.1]
Analysis 3.1. Comparison 3 Zinc vs placebo for acute diarrhoea on day 7: subgroup analysis excluding children < 6 months, Outcome 1 Diarrhoea on day 7.
[Analysis 4.1]
Analysis 4.1. Comparison 4 Zinc vs placebo for persistent diarrhoea, Outcome 1 Diarrhoea duration (h).
[Analysis 4.2]
Analysis 4.2. Comparison 4 Zinc vs placebo for persistent diarrhoea, Outcome 2 Diarrhoea on day 3.
[Analysis 4.3]
Analysis 4.3. Comparison 4 Zinc vs placebo for persistent diarrhoea, Outcome 3 Diarrhoea on day 5.
[Analysis 4.4]
Analysis 4.4. Comparison 4 Zinc vs placebo for persistent diarrhoea, Outcome 4 Diarrhoea on day 7.
[Analysis 4.5]
Analysis 4.5. Comparison 4 Zinc vs placebo for persistent diarrhoea, Outcome 5 Stool frequency (stools/day).
[Analysis 4.6]
Analysis 4.6. Comparison 4 Zinc vs placebo for persistent diarrhoea, Outcome 6 Adverse events (vomiting).
View Full Article (HTML) Summary (57K)Standard (1367K)Full (1568K)